Business Segments · Non-cash charges
Prescription Technology Solutions — Non-cash charges
McKesson Prescription Technology Solutions — Non-cash charges decreased by 100.0% to $0.00 in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2020
Last reportedQ2 2025
How to read this metric
High non-cash charges relative to revenue may suggest heavy investment in intangible assets or technology platforms, impacting GAAP profitability.
Detailed definition
Captures expenses recognized in the income statement that do not involve an immediate cash outflow, specifically within...
Peer comparison
Standard accounting metric used to reconcile GAAP earnings to cash flow, common across all public companies.
Metric ID:
mck_segment_prescription_technology_solutions_non_cash_chargesHistorical Data
5 periods
| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|
| Value | $17.00M | $5.00M | $0.00 | $1.00M | $0.00 |
| QoQ Change | — | -70.6% | -100.0% | — | -100.0% |
| YoY Change | — | -70.6% | -100.0% | — | -100.0% |
Range$0.00 – $17.00M
CAGR-100.0%
Avg YoY Growth-90.2%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — non-cash charges?
- McKesson (MCK) reported prescription technology solutions — non-cash charges of $0.00 in Q2 2025.
- How has McKesson's prescription technology solutions — non-cash charges changed year-over-year?
- McKesson's prescription technology solutions — non-cash charges decreased by 100.0% year-over-year, from $1.00M to $0.00.
- What does prescription technology solutions — non-cash charges mean?
- Expenses that reduce reported earnings but do not involve actual cash payments within the technology solutions segment.